BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
8.94
-0.08 (-0.89%)
At close: Jul 3, 2025, 1:00 PM
8.94
0.00 (0.00%)
After-hours: Jul 3, 2025, 4:38 PM EDT
BioCryst Pharmaceuticals Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$16.70
Upside
+86.80%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $13 → $15 | Strong Buy | Maintains | $13 → $15 | +67.79% | Jul 1, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $13 | Buy | Reiterates | $13 | +45.41% | Jun 30, 2025 |
| Wedbush | Wedbush | Buy Maintains $16 → $18 | Buy | Maintains | $16 → $18 | +101.34% | Jun 30, 2025 |
| Needham | Needham | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +90.16% | Jun 27, 2025 |
| Needham | Needham | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +90.16% | Jun 25, 2025 |
| Barclays | Barclays | Hold Maintains $8 → $11 | Hold | Maintains | $8 → $11 | +23.04% | May 7, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $11 → $13 | Buy | Reiterates | $11 → $13 | +45.41% | May 6, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $10 → $13 | Buy | Maintains | $10 → $13 | +45.41% | May 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +235.57% | May 6, 2025 |
| Needham | Needham | Strong Buy Maintains $15 → $17 | Strong Buy | Maintains | $15 → $17 | +90.16% | May 6, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $20 | Buy | Initiates | $20 | +123.71% | Apr 29, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $11 | Buy | Reiterates | $11 | +23.04% | Apr 11, 2025 |
| Needham | Needham | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +67.79% | Apr 10, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $18 | Buy | Reiterates | $18 | +101.34% | Mar 3, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $10 → $11 | Buy | Reiterates | $10 → $11 | +23.04% | Feb 25, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $18 | Buy | Reiterates | $18 | +101.34% | Feb 25, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.